Navigation Links
Chromos enters into loan and lending arrangements
Date:3/20/2008

tements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Chromos, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

To the extent possible, management implements strategies to reduce or mitigate the risks and uncertainties associated with Chromos' operations. Operating risks include (i) the continued availability of capital to finance Chromos' activities; (ii) Chromos' limited cash position, and (iii) Chromos' limited operations.

CONTACT: Jeff Charpentier, Vice President, Finance and CFO, Tel: (604) 415-7132, Email:jcharpentier@chromos.com; Alistair Duncan, President & CEO, Tel: (604) 415-7121, Email: aduncan@chromos.com, Website: http://www.chromos.com


'/>"/>
SOURCE Chromos Molecular Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
2. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
3. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
4. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
7. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
8. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
9. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
10. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
11. Sangui Partnership Enters a New Phase:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... sustainable chemicals, today announced that the underwriters of its ... to purchase an additional 420,000 shares of common ... per share, less underwriting discounts and commissions, in ... of 2,800,000 shares of common stock, bringing the ...
(Date:7/23/2014)... Cord Blood Corporation (NYSE: CO ) ("CCBC" or the ... collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage ... to the mother and child segment, today announced that the two ... Singapore , Hong Kong , ... the Philippines and Malaysia to ...
(Date:7/23/2014)... July 23, 2014 Astra ... and comprehensive consultancy and pharma training services, and ... Safety (ACRES) , a non-profit integrating the expertise ... and maintain a global system for clinical trials, ... to improve the expertise of industry professionals through ...
(Date:7/22/2014)... a solution of rod-shaped metal nanoparticles in water with ... tiny drill bits. Why? No one yet knows exactly. ... Technology (NIST) have clocked their speedand it,s fast. At ... 10 times faster than any nanoscale object submerged in ... rate has opened up the possibility that they could ...
Breaking Biology Technology:BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... RIDGE, Tenn., Nov. 29, 2007 -- A water repellent ... Ridge National Laboratory outperforms nature at its best and ... super-water repellent (superhydrophobic) material, developed by John Simpson, is ... patent-pending process could lead to the creation of a ...
... CAMBRIDGE, Mass., Nov. 29 Merrimack Pharmaceuticals,Inc., a ... and,development of novel treatments for autoimmune disease and ... PhD from its Board of,Directors and the addition ... as a Director at Merrimack since May 2006. ...
... GRAND RAPIDS, Mich., Nov. 29 The Center ... the first member of the Xceed,Molecular (http://www.xceedmolecular.com ... role, CMM is the first US site to ... analysis, giving researchers an,important new tool in disease ...
Cached Biology Technology:ORNL super water repellent could cause big wave in market 2Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors 2Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors 3Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community 2
(Date:7/23/2014)... tapeworms, hookworms and a protist called Blastocystis can ... that argues we should rethink our views of organisms that ... paper co-author Julius Luke even ingested three developmental stages of ... After more than a year with the tapeworms, which might ... by now, he says he feels fine. , "I knew ...
(Date:7/23/2014)... and rosemary are packed with healthful compounds, and now ... same way as prescription anti-diabetic medication, scientists report. In ... Agricultural and Food Chemistry , they found that how ... also identified which compounds contribute the most to this ... point out that in 2012, type-2 diabetes affected more ...
(Date:7/23/2014)... preconditioning has been confirmed by many studies, but ... released in the Neural Regeneration Research ... and co-workers from Tongji Hospital Affiliated to Tongji ... China performed cerebral ischemic preconditioning in rats by ... mechanism underlying the neuroprotective effect of ischemic preconditioning. ...
Breaking Biology News(10 mins):Intestinal parasites are 'old friends,' researchers argue 2Intestinal parasites are 'old friends,' researchers argue 3
... 2014   BioNano Genomics announced today the purchase of an ... projects, in completing the genome assembly of Aegilops tauschii, ... researchers at UC Davis, led by Dr. Jan Dvorak , ... the sequence, location, and orientation of all genes and transposable elements ...
... the genome might be important contributors to type 2 diabetes ... don,t encode proteins were once dismissed as "junk DNA", but ... controlling which genes are switched on. The new study, ... first to show how such regions, called regulatory elements, can ...
... Almost one in 10 people will someday experience a kidney ... pain imaginable. This increasingly common condition leads to hundreds of ... A new device developed at the University of Washington would ... body and help them pass by natural means. "Ultrasound ...
Cached Biology News:UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 3UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 4UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 5Non-coding DNA implicated in type 2 diabetes 2Trial to test using ultrasound to move kidney stones 2Trial to test using ultrasound to move kidney stones 3
... anti-phospho-PTEN (Ser385) ... amino acid region encompassing the ... (Ser385), Accession ... Quality Assurance: Routinely ...
Mouse monoclonal [YLI-90] to Ly49I (Biotin) ( Abpromise for all tested applications)....
TNR-R2...
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: